Skip to main content

Featured

U.S. Seizure of Russian-Flagged Tanker Heightens Global Tensions

The ship, currently between Iceland and the British Isles, has been accused of breaking US sanctions and shipping Iranian oil. It has historically transported Venezuelan crude oil. The United States has seized a Russian‑flagged oil tanker linked to Venezuela after a prolonged pursuit across the Atlantic, marking one of the most assertive enforcement actions under Washington’s sanctions program. The vessel, previously known as Bella‑1 and later renamed Marinera , was intercepted after evading an earlier boarding attempt near Venezuelan waters. U.S. military aircraft and naval units tracked the ship for weeks as it traveled across the Atlantic, at times shadowed by Russian naval vessels. Officials say the tanker was part of a network used to transport sanctioned Venezuelan and Russian oil. Its capture underscores Washington’s efforts to disrupt what it describes as illicit energy shipments that help sustain both governments. The operation comes at a delicate geopolitical moment, wit...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment